Simon N.R. Harford - Jan 11, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
CFO and Treasurer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 11, 2022
Transactions value $
-$2,880
Form type
4
Date filed
1/11/2022, 04:38 PM
Previous filing
Oct 12, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$2.88K -111 -0.87% $25.95 12.7K Jan 11, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 6,257 shares of common stock and 6,438 restricted stock units. Includes 192 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on November 30, 2021.